We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$663M
AUM Growth
+$70.5M
Cap. Flow
+$41.2M
Cap. Flow %
6.22%
Top 10 Hldgs %
59.59%
Holding
99
New
18
Increased
4
Reduced
2
Closed
7
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
PACX
Pioneer Merger Corp. Class A Ordinary Share
PACX
+$20.9M
2
EQRX
EQRx, Inc. Common Stock
EQRX
+$10.2M
3
ISPC icon
iSpecimen
ISPC
+$4.32M
4
AENT icon
Alliance Entertainment
AENT
+$3.89M
5
MRNS icon
Marinus Pharmaceuticals, Inc
MRNS
+$3.74M

Top Sells

Rank Stock Value
1
FLNA icon
Filana Therapeutics
FLNA
+$6.7M
2
ADRA.U
Adara Acquisition Corp Units
ADRA.U
+$3.97M
3
DISH
DISH Network Corp.
DISH
+$2.81M
4
BRPMU
B. Riley Principal 150 Merger Corp. Unit
BRPMU
+$2.25M
5
WGS icon
GeneDx Holdings
WGS
+$1.49M

Sector Composition

Rank Sector Weight
1 Healthcare 26%
2 Industrials 13.45%
3 Miscellaneous 12.78%
4 Consumer Discretionary 11.5%
5 Financials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$78.7M 11.87%
475,000
– –
2019 Q4
6 quarters
LIN icon
2
Linde
LIN
$228B
$55.7M 8.4%
192,627
– –
2019 Q4
6 quarters
BC icon
3
Brunswick
BC
$4.2B
$49.8M 7.51%
500,000
– –
2020 Q1
5 quarters
DRRX icon
4
DELISTED
DURECT Corp
DRRX
$43.1M 6.5%
2,641,466
– –
2019 Q4
6 quarters
INVE icon
5
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$37.3M 5.63%
2,196,389
– –
2019 Q4
6 quarters
IVAC icon
6
DELISTED
Intevac Inc
IVAC
$33.4M 5.03%
4,949,355
– –
2019 Q4
6 quarters
FLNA icon
7
Filana Therapeutics
FLNA
$35.4M
$32M 4.83%
375,000
-125,000
-25% -$6.7M
2019 Q4
6 quarters
OPTU icon
8
Optimum Communications Inc
OPTU
$355M
$24.9M 3.75%
728,600
+25,000
+4% +$875K
2020 Q1
5 quarters
PACX
9
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$21.1M 3.18%
+2,125,000
New +$20.9M
2021 Q2
0 quarters
MRNS icon
10
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$19.1M 2.88%
1,062,500
+232,590
+28% +$3.74M
2020 Q1
5 quarters
IDN icon
11
Intellicheck
IDN
$44.8M
$17.4M 2.62%
2,073,583
– –
2019 Q4
6 quarters
SPGI icon
12
S&P Global
SPGI
$125B
$16.4M 2.48%
40,000
– –
2019 Q4
6 quarters
LIQT icon
13
LiqTech
LIQT
$12.2M
$15.8M 2.38%
269,806
– –
2020 Q1
5 quarters
GRA
14
DELISTED
W.R. Grace & Co.
GRA
$13.9M 2.1%
200,934
– –
2020 Q1
5 quarters
SHLX
15
DELISTED
Shell Midstream Partners, L.P.
SHLX
$13.5M 2.04%
913,347
– –
2019 Q4
6 quarters
CDXS icon
16
Codexis
CDXS
$146M
$13.1M 1.98%
579,116
– –
2019 Q4
6 quarters
THO icon
17
Thor Industries
THO
$3.58B
$12.4M 1.87%
109,753
– –
2020 Q1
5 quarters
FNCH icon
18
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$11.4M 1.72%
27,014
– –
2021 Q1
1 quarter
LSXMK icon
19
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$11M 1.65%
305,187
– –
2019 Q4
6 quarters
EQRX
20
DELISTED
EQRx, Inc. Common Stock
EQRX
$10.3M 1.56%
+1,000,000
New +$10.2M
2021 Q2
0 quarters
ISLE
21
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$9.8M 1.48%
1,000,000
– –
2021 Q1
1 quarter
FATE icon
22
Fate Therapeutics
FATE
$231M
$8.68M 1.31%
100,000
– –
2020 Q2
4 quarters
RPRX icon
23
Royalty Pharma
RPRX
$26.6B
$8.2M 1.24%
200,000
– –
2020 Q2
4 quarters
NS icon
24
DELISTED
NuStar Energy L.P.
NS
$7.86M 1.19%
435,500
– –
2019 Q4
6 quarters
BX icon
25
Blackstone
BX
$86.9B
$7.77M 1.17%
80,000
– –
2019 Q4
6 quarters
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q2 2021 Portfolio in Review

As of Q2 2021, Bleichroeder LP held 99 positions worth $663M, up 12% from $592M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Bleichroeder LP deployed $41.2M of net new capital in Q2 2021, opening 18 new positions and adding to 4 existing holdings. Its largest new stake was Pioneer Merger Corp. Class A Ordinary Share: 2,125,000 shares worth $21.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Miscellaneous.

On the sell side, the largest reduction was Filana Therapeutics, an estimated $6.7M trimmed.

  • Bleichroeder LP's largest Q2 2021 buy was Pioneer Merger Corp. Class A Ordinary Share: 2,125,000 shares worth $21.1M.
  • Bleichroeder LP added most to Marinus Pharmaceuticals, Inc in Q2 2021, an estimated $3.74M increase.
  • Bleichroeder LP's biggest Q2 2021 reduction was Filana Therapeutics, cutting an estimated $6.7M.
  • Bleichroeder LP fully exited Adara Acquisition Corp Units in Q2 2021, selling an estimated $3.97M.
  • Bleichroeder LP's ten largest holdings make up 60% of its $663M portfolio in Q2 2021.
  • Bleichroeder LP opened 18 new positions and closed 7 in Q2 2021.
  • Bleichroeder LP's portfolio value rose 12% quarter-over-quarter to $663M.

Based on Bleichroeder LP's 13F filing for Q2 2021, filed 16 Aug 2021.